Skip to search.
 TSX Up 0.30% TSX Ventures Down 0.15%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
1.98 Down 0.04(1.98%) Jul 2, 4:00PM EDT
Add to Portfolio
Prev Close:2.02
Open:2.01
Bid:1.90 x 100
Ask:2.02 x 1000
1y Target Est:5.25
Beta:1.64
Earnings Date:Aug 3 - Aug 7 (Est.)
Day's Range:1.97 - 2.02
52wk Range:1.65 - 2.96
Volume:800,043
Avg Vol (3m):3,328,440
Market Cap:356.88M
P/E (ttm):N/A
EPS (ttm):-0.61
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
CTICDown 1.98%356.88M
BMYDown 0.28%112.49B
RHHBYUp 0.09%N/A
SNYDown 0.58%129.36B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.72
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.39
Quarterly EPS Est (Jun-15) :-0.11
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback